N/A N=562 Screening for Hesitancy to Optimize Talk
Preventive Health Services
Primary: Child's Mean Percent Days Under-immunized — 19.1; 25.2 percentage of days under-immunized — p=.29
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=756 Views on COVID-19 and Vaccination
Covid19
Primary: Number of Participants Who Became Less Hesitant About the COVID-19 Vaccine After Receiving a Physician Message — 23; 26; 43; 35 Participants
N/A N=60 VISTA: Vaccinator-Initiated Screening and TAilored Counseling for Reducing Vaccine Hesitancy
Vaccination Uptake
Primary: Percentage of Women With Reduced Number of Concerns Immediately Post-counseling in the Intervention Arm — 51.72 percentage of women
N/A N=456 A Chatbot Intervention for Reducing HPV Vaccine Hesitancy
Cervical Cancer · Anal Cancer · Penile Cancer
Primary: Attitudes Toward HPV Vaccination — 3.86; 3.96; 3.41 score on a scale
N/A N=338,718 Developing and Testing a COVID-19 Vaccination Acceptance Intervention
COVID-19 Vaccination
Primary: Receipt of Any Dose COVID-19 Vaccination — 57621; 65407 Participants — p=0.202
N/A N=17,446 Presumptively Initiating Vaccines and Optimizing Talk With Motivational Interviewing (PIVOT With MI)
Preventive Health Services (PREV HEALTH SERV)
Primary: Child Immunization Status at 19 Months, 0 Days of Age Characterized as Percent Days Under-immunized (DUI) — 32; 24 percentage of days under-immunized — p=0.9
N/A N=148 Healthy, Immunized Communities Study
Vaccine Hesitancy · Communicable Diseases in Children
Primary: Percentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV) — 74.3; 83.3; 97.9; 93.0 percentage of participants
N/A N=1,419 Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression
Misinformation · Vaccine Hesitancy · Anxiety
Primary: Self-reported Receipt of COVID Vaccine Dose by 4 Weeks Post-intervention — 4; 7; 6; 462 Participants
N/A N=312 CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19)
COVID-19 · Vaccine Refusal
Primary: Percentage of Participants Who Plan to Receive a COVID-19 Vaccine Post-intervention — 19; 24; 19; 21 Participants
N/A N=2,701 COVID-19 Vaccination Take-Up
Covid19 · Vaccination
Primary: Rate of COVID-19 Vaccination at 1 Month — 12; 4; 0; 1 Participants
N/A N=228,831 Precision Vaccine Promotion in Underserved Populations
Influenza · Vaccine Hesitancy
Primary: Number of Participants Vaccinated at the End of the Campaign Period — 33357; 854 Participants — p=0.216
N/A N=2,097 Exploring Changes in COVID-19 Vaccination Intentions by Prompting Altruistic Motives Using a Video Intervention
Vaccine Refusal
Primary: Post Intervention Vaccine Intentions — 54; 47; 236; 249 Participants
N/A N=510 Promoting Altruism to Enhance Vaccine Acceptance
Vaccine Refusal
Primary: Change in Vaccine Hesitancy Scores Pre- and Post-Intervention. — -0.4 units on a scale
N/A N=20 COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial
COVID-19
Primary: Mean Fidelity Score — 18.1; 18.4 score on a scale
N/A N=2,868 Increasing Vaccine Uptake Among Adolescents in the Rural South
Vaccine Hesitancy
Primary: Difference in the Percentage of Adolescents Who Ever Received at Least One Dose of HPV Vaccination in the Intervention Group After the Intervention Implementation…
N/A N=23,768 Improving COVID-19 Vaccine Uptake in Nursing Homes
COVID-19 Vaccines
Primary: Number of Residents Who Received SARS-CoV-2 Vaccine — 3083; 2994 Participants
N/A N=251 COVID-19 Vaccine Uptake Trial
Vaccination Refusal · COVID-19
Primary: Vaccine Uptake — 1; 3; 1; 0 Participants
N/A N=70 Vax Facts Human Papillomavirus (HPV): Study of a Computer-based Tailoring System and Mothers' Intentions to Vaccinate Their Daughters Against HPV
Human Papillomavirus · Prevention
Primary: Mother's Intention to Vaccinate Daughter Against HPV — 1.53; 1.29 units on a scale
N/A N=360 Addressing Vaccine Hesitancy and Increasing COVID-19 Vaccine Uptake Among African American Young Adults in the South
COVID-19 · Vaccine Uptake
Primary: COVID Vaccine Uptake at Month 1 — 6; 5 Participants
N/A N=9,566 Emails Promoting COVID-19 Vaccination Among Healthcare Workers
Vaccination Refusal · Communication
Primary: Number of Employees Who Scheduled Vaccination Appointments After 3 Days — 101; 207; 220 Participants — p=<.001
N/A N=6 COVID-19 Messaging for Vaccination
Vaccination Refusal · COVID-19 Pandemic
Primary: Changes in County-Level Covid-19 Vaccination Measured by Inverse Hyperbolic Sine — 0; -0.023; -0.007; -0.037 asinh(new dose 1s of vaccine)
N/A N=56 Impact of LA-CEAL HALT COVID-19 Ambassador Program on Likelihood to Vaccinate
Covid19 · Vaccine Refusal
Primary: Difference in Proportion of Participants "Likely to Vaccinate" Between Study Arms at Month 1 — 1; 3 Participants
N/A N=674 Improving COVID-19 Vaccine Uptake Among Black and Latino Youth
COVID-19
Primary: COVID-19 Vaccination Rate for Eligible Children — 21.3; 33.5; 16.4; 26.7 Percent of participants vaccinated
N/A N=3,076 SDH of HPV Vaccine Completion
Human Papilloma Virus
Primary: Overall HPV Vaccine Completion Rates — 1961; 1083 Participants
N/A N=1,180 Getting to Yes, Michigan! (G2YMI)
COVID-19 Vaccines · COVID-19 Pandemic
Primary: Self-reported COVID-19 Vaccine Uptake — 117; 123 Participants
N/A N=1,934 Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool
COVID-19 Vaccines · Telemedicine · Vaccine Hesitancy
Primary: Proportion of Children Who Complete COVID-19 Vaccination, as Verified in State, Clinic, or Participant-held Records — 13; 7 Participants
N/A N=3,245 Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects
Flu, Human · Influenza, Human · Covid19
Primary: Rating of Sender — .1828917; -.0750636; .0997998; -.5397662 index
Phase 4 N=182 Immunogenicity of Hepatitis B Vaccination in HIV-infected Adults
Hepatitis B Vaccine
Primary: Number and Percentage of Participants With Anti-HBs Seroconversion at Month 7 — 75; 69 Participants
N/A N=19,554 COVID-19 Vaccine Text Outreach
Covid19
Primary: Dose 1 Completion — 14; 243; 253 Participants
N/A N=2,554 Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination
Papillomavirus Vaccines
Primary: Human Papillomavirus or HPV-vaccine-dose Receipt — 782; 578; 408; 1056 Participants